Determining priority signs and symptoms for use as clinical outcomes assessments in trials including patients with malignant gliomas: Panel 1 Report

Author(s):
Armstrong, T.S.; Bishof, A.M.; Brown, P.D.; Klein, M.; Taphoorn, M.J.B.; Theodore-Oklota, C.
Published
2016
Publication type
Article / Letter to editor
clinical outcomes assessmentglioblastomagliomaoutcomessigns and symptoms
Date issued
2016-03-31
Language
English
Is part of
Neuro-Oncology (2016), Vol. 18, p. 1-12
hdl
1887/113086
doi
10.1093/neuonc/nov267